Literature DB >> 6712288

Lymphoproliferative malignancy in rheumatoid arthritis: a study of 20 cases.

D P Symmons, M Ahern, P A Bacon, C F Hawkins, P L Amlot, E L Jones, P Prior, D L Scott.   

Abstract

A series of 20 patients with definite or classical rheumatoid arthritis who subsequently developed a lymphoproliferative malignancy are described. The mean time between the onset of the 2 diseases was 13.2 years. A wide range of types of non-Hodgkin's lymphoma and Hodgkin's disease were found; there were no unusual histological features in the lymphomas. Although many of the patients had had gold, penicillamine, and other second-line drugs, none of them had received cytotoxic drugs, and there was no evidence that therapy was a cause of their malignancies. The likely cause of the association is a predisposition to both diseases.

Entities:  

Mesh:

Year:  1984        PMID: 6712288      PMCID: PMC1001447          DOI: 10.1136/ard.43.2.132

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

1.  COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.

Authors:  J J DUTHIE; P E BROWN; L H TRUELOVE; F D BARAGAR; A J LAWRIE
Journal:  Ann Rheum Dis       Date:  1964-05       Impact factor: 19.103

2.  The association of immune disease and malignant lymphoma.

Authors:  D G Miller
Journal:  Ann Intern Med       Date:  1967-03       Impact factor: 25.391

3.  Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm.

Authors:  J Zulman; R Jaffe; N Talal
Journal:  N Engl J Med       Date:  1978-11-30       Impact factor: 91.245

4.  Leukaemia-like appearances in mice given penicillamine.

Authors:  G Harris
Journal:  Lancet       Date:  1976-12-18       Impact factor: 79.321

5.  Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis.

Authors:  H A Isomäki; T Hakulinen; U Joutsenlahti
Journal:  J Chronic Dis       Date:  1978

6.  Leukemia or lymphoma occurring subsequent to an autoimmune disease.

Authors:  A Oleinick
Journal:  Blood       Date:  1967-01       Impact factor: 22.113

7.  Increased mortality in rheumatoid arthritis.

Authors:  P Allebeck
Journal:  Scand J Rheumatol       Date:  1982       Impact factor: 3.641

8.  Frequency of neoplasia in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  R B Lewis; C W Castor; R E Knisley; G G Bole
Journal:  Arthritis Rheum       Date:  1976 Nov-Dec

9.  Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine.

Authors:  P Lewis; B L Hazleman; R Hanka; S Roberts
Journal:  Ann Rheum Dis       Date:  1980-10       Impact factor: 19.103

10.  Systemic lupus erythematosus and lymphoma.

Authors:  J A Green; A A Dawson; W Walker
Journal:  Lancet       Date:  1978-10-07       Impact factor: 79.321

View more
  14 in total

1.  Safety of extended treatment with anakinra in patients with rheumatoid arthritis.

Authors:  R M Fleischmann; J Tesser; M H Schiff; J Schechtman; G-R Burmester; R Bennett; D Modafferi; L Zhou; D Bell; B Appleton
Journal:  Ann Rheum Dis       Date:  2006-01-05       Impact factor: 19.103

2.  Characteristics and prognosis of colorectal cancer associated with rheumatic disease.

Authors:  Junko Kishikawa; Kazushige Kawai; Nelson H Tsuno; Soichiro Ishihara; Hironori Yamaguchi; Eiji Sunami; Toshiaki Watanabe
Journal:  Int Surg       Date:  2015-01-04

3.  Evidence for oligoclonal B cell expansion in the peripheral blood of patients with rheumatoid arthritis.

Authors:  D A Fox; B R Smith
Journal:  Ann Rheum Dis       Date:  1986-12       Impact factor: 19.103

4.  Rheumatoid lymphadenopathy: a morphological and immunohistochemical study.

Authors:  G M Kondratowicz; D P Symmons; P A Bacon; R A Mageed; E L Jones
Journal:  J Clin Pathol       Date:  1990-02       Impact factor: 3.411

5.  No overall increased risk of cancer in patients with rheumatoid arthritis: a nationwide dynamic cohort study in Taiwan.

Authors:  Wen-Kuan Huang; Meng-Jiun Chiou; Chang-Fu Kuo; Yung-Chang Lin; Kuang-Hui Yu; Lai-Chu See
Journal:  Rheumatol Int       Date:  2014-03-27       Impact factor: 2.631

Review 6.  Rheumatological manifestations of haematological diseases.

Authors:  S Menon; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1995-10       Impact factor: 19.103

7.  Symmetrical polyarthritis is not always rheumatoid.

Authors:  N Menon; R Madhok
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

8.  Rheumatoid arthritis and malignant histiocytosis of the intestine.

Authors:  C Cooper; M I Cawley
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

9.  Prognostic significance of paraproteinaemia in rheumatoid arthritis.

Authors:  C Kelly; G Baird; H Foster; H Hosker; I Griffiths
Journal:  Ann Rheum Dis       Date:  1991-05       Impact factor: 19.103

10.  Risk of cancer among rheumatoid arthritis patients in California.

Authors:  Arti Parikh-Patel; Richard H White; Mark Allen; Rosemary Cress
Journal:  Cancer Causes Control       Date:  2009-01-28       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.